The study suggests that abnormal RLR signaling, or dysregulation of RLR expression, is associated with the development of autoimmune diseases, and understanding RLR signaling and response will provide insights to guide RLR‐targeted therapy in antiviral and immunomodification applications.35 The gene discussed is DHX58; the disease is autoimmune disease.